MRI治疗反应评估图(TRAMs)用于鉴别复发性胶质母细胞瘤与放射性坏死
回顾性分析27例经组织学证实的胶质母细胞瘤患者共29次再次手术或活检前的TRAMs,其中28次活检为复发性胶质母细胞瘤、1次为放射性坏死。复发性胶质母细胞瘤的 wash-out 体积与肿瘤体积比值为36±17%,wash-out 体积与 wash-out 加 wash-in 体积之和的比值为48±21%;放射性坏死病例分别为42%和54%。作者认为典型复发性胶质母细胞瘤的 wash-out 体积与 wash-out 加 wash-in 体积之和的比值>20%,但放射性坏死个别病例也可出现高 wash-out,TRAMs 提供的额外信息可提高诊断可靠性。
要点
- 27例胶质母细胞瘤患者共29次再次手术/活检,28次病理为复发胶质母细胞瘤、1次为放射性坏死。
- 复发性胶质母细胞瘤的 wash-out 体积与肿瘤体积比值为36±17%(范围1-73%)。
- 复发性胶质母细胞瘤的 wash-out 体积与 wash-out 加 wash-in 体积之和的比值为48±21%(范围22-92%)。
核心结论
- 典型复发性胶质母细胞瘤的 wash-out 体积与 wash-out 加 wash-in 体积之和的比值>20%。
- 唯一一例放射性坏死活检显示此类坏死在个别病例中也可产生高 wash-out。
- TRAMs 提供的额外信息可提高诊断的可靠性。
研究设计与样本
- 回顾性评估2017年1月1日至2022年12月31日期间经组织学证实为胶质母细胞瘤、有对比增强组织且术前接受MRI的成人患者的TRAMs。
- 仅纳入接受再次活检或手术的患者,分析第二次手术前的残留肿瘤体积、对比剂清除体积和对比剂积聚体积。
- 在339例接受MRI的mGBM患者中,识别出27例患者的29次再次手术/活检,年龄59±12岁(均值±标准差)。
主要发现
- 29次活检中28次来自复发性胶质母细胞瘤组织学患者,仅1次来自放射性坏死患者。
- 复发性胶质母细胞瘤的 wash-out 体积与肿瘤体积比值为36±17%(范围1-73%)。
- 复发性胶质母细胞瘤的 wash-out 体积与 wash-out 加 wash-in 体积之和的比值为48±21%(范围22-92%)。
- 放射性坏死那1次活检的上述两个比值分别为42%和54%。
临床怎么用
- 作者认为典型复发性胶质母细胞瘤的 wash-out 体积与 wash-out 加 wash-in 体积之和的比值>20%。
- 作者认为TRAMs提供的额外信息可提高诊断的可靠性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: MRI treatment response assessment maps (TRAMs) were introduced to distinguish recurrent malignant glioma from therapy related changes. TRAMs are calculated with two contrast-enhanced T1-weighted sequences and reflect the "late" wash-out (or contrast clearance) and wash-in of gadolinium. Vital tumor cells are assumed to produce a wash-out because of their high turnover rate and the associated hypervascularization, whereas contrast medium slowly accumulates in scar tissue. To examine the real value of this method, we compared TRAMs with the pathology findings obtained after a second biopsy or surgery when recurrence was suspected. METHODS: We retrospectively evaluated TRAMs in adult patients with histologically demonstrated glioblastoma, contrast-enhancing tissue and a pre-operative MRI between January 1, 2017, and December 31, 2022. Only patients with a second biopsy or surgery were evaluated. Volumes of the residual tumor, contrast clearance and contrast accumulation before the second surgery were analyzed. RESULTS: Among 339 patients with mGBM who underwent MRI, we identified 29 repeated surgeries/biopsies in 27 patients 59 ± 12 (mean ± standard deviation) years of age. Twenty-eight biopsies were from patients with recurrent glioblastoma histology, and only one was from a patient with radiation necrosis. We volumetrically evaluated the 29 pre-surgery TRAMs. In recurrent glioblastoma, the ratio of wash-out volume to tumor volume was 36 ± 17% (range 1-73%), and the ratio of the wash-out volume to the sum of wash-out and wash-in volumes was 48 ± 21% (range 22-92%). For the one biopsy with radiation necrosis, the ratios were 42% and 54%, respectively. CONCLUSIONS: Typical recurrent glioblastoma shows a > 20%ratio of the wash-out volume to the sum of wash-out and wash-in volumes. The one biopsy with radiation necrosis indicated that such necrosis can also produce high wash-out in individual cases. Nevertheless, the additional information provided by TRAMs increases the reliability of diagnosis.
引用
- Müller SJ, Khadhraoui E, Ganslandt O, et al. MRI Treatment Response Assessment Maps (TRAMs) for differentiating recurrent glioblastoma from radiation necrosis. J Neurooncol. 2024. PMID: 38261142. doi:10.1007/s11060-024-04573-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。